Synermore Biologics (suzhou) Co., Ltd.

This study follows 232 children under 18 who had a severe (Category III) animal bite and received a new antibody treatment (zamerovimab and mazorelvimab) plus the rabies vaccine. The goal is to see how many children survive without rabies at 3 months and 1 year. Researchers also …